Modulating pyrimidine ribonucleotide levels for the treatment of cancer. | Cancer Metab;8: 12, 2020. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Modulating pyrimidine ribonucleotide levels for the treatment of cancer.

Mollick, Tanzina; Laín, Sonia.

Affiliation

Mollick T; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, SE-171 65, Solna, Stockholm, Sweden.
Laín S; SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Tomtebodavägen 23, SE-171 65, Solna, Stockholm, Sweden.

Cancer Metab ; 8: 12, 2020.

Article in En | MEDLINE | ID: mdl-33020720

Key words

CAD; CDA; CTPS; Cancer therapy; DHODH; Nucleoside transporters; Pyrimidine ribonucleotide metabolism; Therapeutic index; UMPS

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Metab Year: 2020 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Metab Year: 2020 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido